[Policy Recommendations] The 6 Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Obesity Control (November 1, 2023)
The Health and Global Policy Institute (HGPI) Obesity Control Promotion Project has presented policy recommendations titled, “The 6 Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Obesity Control.”
These recommendations are based on findings from the Global Expert Meeting “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Obesity Control.” hold on 31 March 2023.
- Recommendation 1: The definition of obesity that requires medical intervention must be broadly disseminated throughout society, people living with obesity of the type that necessitates medical intervention must be identified, and ongoing efforts to establish all types of relevant guidelines based on scientific evidence must continue.
- Recommendation 2: When treating cases of obesity that require medical intervention, in addition to involving physicians and healthcare institutions specializing in obesity, it will also be necessary to promote multidisciplinary cooperation and collaboration with family doctors and occupational physicians.
- Recommendation 3: The causative factors of obesity are diverse and complex. Rather than limiting ourselves to the concept of personal responsibility and only viewing obesity as the result of overeating and physical inactivity, we must reaffirm the issues that create factors for obesity for the parties most affected and in society as a whole with a perspective that encompasses the Social Determinants of Health (SDH).
- Recommendation 4: Based on the diversity and complexity of the causative factors of obesity, collaboration with and involvement from broad stakeholders must be expanded so a greater variety of obesity interventions can be provided.
- Recommendation 5: The prevalence of general obesity and obesity requiring medical intervention vary among countries and regions, so research in Japan must be enhanced and evidence- and data-based policies must be expanded.
- Recommendation 6: Health promotion measures that affected parties consider harmonious, must be promoted by building health information networks and health data systems that encompass obesity control and the entire health system.
Please check the attachment for details.
Global Expert Meeting “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Obesity Control”
- Date & Time: Friday, March 31, 2023 15:00-17:30 JST
- Format: Hybrid format
(Zoom webinar and in-person lecture at Global Business Hub Tokyo)
- Venue: Global Business Hub Tokyo
(Otemachi Financial City, 1-9-2 Otemachi, Chiyoda-ku, Tokyo)
- Host by: Health and Global Policy Institute (HGPI)
- Sponsored by: National Graduate Institute for Policy Studies (GRIPS) Global Health Innovation Policy Program (GHIPP)
Novo Nordisk Pharma Ltd.
- Supported by: Royal Danish Embassy
- Languages: Japanese/English (with simultaneous interpretation)
- Participation fee: Free
- Capacity: In-person 60 people, Online 200 people
[Program] JST (title omitted, in alphabetical order, tentative)
|15:00-15:10||Opening Remarks and Overview; Introduction of Discussion Points by Health and Global Policy Institute|
|Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute)|
|15:15-15:30||Keynote Lecture 1 “Future Challenges and Prospects in Obesity Control in Japan”|
|Koutaro Yokote (President, Japan Society for the Study of Obesity; Director General,Chiba University Hospital)|
|15:30-15:40||Keynote Lecture 2 “Policy Status of Chronic Disease Control including Obesity Control”|
|Kazutaka Tanabe (Director, Women’s Health Promotion Office, Health Service Division,Health Service Bureau, Ministry of Health, Labour and Welfare)|
|15:45-16:00||Keynote Lecture 3 “Lessons from Overseas: Multi-stakeholder Collaboration for Obesity Control”|
|Diana Arsovic Nielsen (CEO, Danish Life Science Cluster)|
|16:10-17:20||Panel Discussion “Next Steps Needed in Obesity Control”|
Yuko Oguma (Associate Professor, Sports Medicine Research Center, Graduate School of Health Management, Keio University)
Iwao Kurose (Executive Director, Japan Medical Association)
Naoki Kondo (Professor and Chair, Department of Social Epidemiology, Graduate School of Medicine and School of Public Health, Kyoto University)
Ichiro Tatsuno (President, Chiba Prefectural University of Health Sciences)
Alexandra Søgaard Helbo (Senior Scientific Manager, PhD, Obesity and Nutritional Sciences,the Novo Nordisk Foundation)
|Keizo Takemi (Member, House of Councillors)|